Leukeran 2mg u?

Leukeran (5‑fluorouracil, 5‑FU)
Leukeran is the brand name for the chemotherapy drug 5‑fluorouracil (5‑FU). It is a cytotoxic agent that interferes with DNA synthesis in rapidly dividing cells, most commonly used to treat certain leukemias (e.g., acute lymphoblastic leukemia) and some solid tumors when given as an intrathecal (in‑spinal) injection or via a central venous catheter.

---

Typical dosing (general information)

Route	Typical dose	Frequency	Notes
Intrathecal (lumbar puncture or Ommaya reservoir)	25 µg – 200 µg (often 2–5 mg/m² of body surface area, but actual dosing is usually expressed in micrograms)	Every 3–7 days (depends on protocol)	Never use the “oral” or “IV” 2 mg dose for intrathecal administration.
Systemic IV (not standard for Leukeran)	25 mg/m² (usually as a 30‑min infusion)	Every 3–4 days	This is the typical “body‑surface‑area” dose used in some regimens.
Subcutaneous (rare)	5–10 mg per dose	Daily	Some regimens use daily SC injections for certain leukemia protocols.

Key point: The 2 mg figure you mentioned is not a standard dose for any approved route of administration. 5‑FU dosing is typically expressed in micrograms or mg /m². If you see a 2 mg prescription, it may be a typo or a non‑standard off‑label use that should be verified with a prescriber.

---

Why 5‑FU is used in leukemia

• Mechanism: 5‑FU is incorporated into RNA and DNA, disrupting cell division and leading to apoptosis in rapidly dividing leukemic cells.
• Common indications:
  • Acute lymphoblastic leukemia (ALL) – often part of multi‑agent induction regimens.
  • Certain solid tumors when given intrathecally to treat or prevent central nervous system (CNS) relapse.

---

How it is administered

• Intrathecal injection: Delivered into the cerebrospinal fluid via lumbar puncture or through a ventricular reservoir (Ommaya).
  • Requires sterile technique and precise dosing—small errors can lead to neurotoxicity.
• Central venous catheter: For systemic use, 5‑FU is infused through a peripherally inserted central catheter (PICC) or central line.

---

Common side effects

System	Common adverse events	Severity
Hematologic	Neutropenia, anemia, thrombocytopenia	Often dose‑limiting
Gastrointestinal	Nausea, vomiting, mucositis, diarrhea	Mild‑moderate (may require anti‑emetics)
Cutaneous	Alopecia (hair loss), skin rash, nail changes	Usually mild
Neuro‑toxic (intrathecal)	Headache, chemical meningitis, seizures, permanent neuro deficits	Rare but serious
Hepatic	Elevated transaminases, cholestasis	Monitor LFTs

---

Contraindications & cautions

• Pregnancy / breastfeeding – teratogenic; avoid.
• Hepatic impairment – dose adjustment may be required.
• Allergy to 5‑FU or other fluoropyrimidines – contraindicated.
• Concurrent radiation – increased risk of skin toxicity.
• Concurrent use of certain drugs (e.g., methotrexate, warfarin) – monitor for interactions.

---

Drug interactions

Drug	Interaction	What to do
Methotrexate	Both are cytotoxic; combined toxicity ↑	Monitor for myelosuppression and renal toxicity
Warfarin	5‑FU may increase bleeding risk	Monitor INR closely
Other chemo agents (e.g., vincristine)	Additive myelotoxicity	Dose adjustment or increased monitoring

---

Storage

• Keep refrigerated (2–8 °C).
• Protect from light.
• Use within 30 days of reconstitution (check specific product insert).

---

When to seek medical help

• Signs of severe neutropenia (fever > 38 °C, chills).
• Severe mucositis or GI bleeding.
• Neurologic symptoms after intrathecal injection (seizures, severe headache, confusion).
• Signs of anaphylaxis (rash, itching, swelling of face/neck, difficulty breathing).

---

Bottom line for the 2 mg question

• 2 mg is not a standard dose for Leukeran.
• If you received a prescription or label stating 2 mg, double‑check with your prescriber or pharmacist.
• For intrathecal use, doses are usually in the microgram range; for systemic use, the dose is calculated based on body‑surface area (mg/m²).

---

How to proceed

1. Confirm the exact route (intrathecal, IV, SC).
2. Verify the intended dose with your prescribing clinician—if it is indeed 2 mg, they likely mean 2 mg/m² or 2 mg per specific protocol.
3. Ask the pharmacist about the specific vial concentration (commonly 500 mg/mL for 5‑FU; 2 mg would be a tiny aliquot).

---

Reminder: All chemotherapy decisions should be made by a qualified healthcare professional who can tailor dosing to your specific condition, body size, organ function, and concurrent medications. If you’re unsure or have any symptoms while on Leukeran, contact your oncologist or pharmacist immediately.